About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
GLP-1RA
- Company
- Kaiser Permanente
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 30 recruiting
Efficacy results: Not yet reported
30 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026
Find a Clinical Trial Near Me
See recruiting studies for GLP-1RA and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT05349955
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
Not yet reported Shanghai Zhongshan Hospital 5600 participants Est. completion 2026-11-30 13 sites Stand-aloneType 2 diabetesChronic kidney disease Other conditions: Cardiovascular ComplicationView official trial listing → -
Recruiting NCT NCT06082063
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Not yet reported Steno Diabetes Center Copenhagen 2000 participants Est. completion 2029-07-01 2 sitesCardiovascular diseaseHeart failure Other conditions: Type 1 Diabetes, Kidney FailureView official trial listing → -
Recruiting NCT NCT06256419
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
Not yet reported The Affiliated Hospital of Xuzhou Medical University 300 participants Est. completion 2028-01-31 1 site Stand-aloneType 2 diabetes Other conditions: Susceptibility, GeneticView official trial listing → -
Recruiting NCT NCT06338553
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Not yet reported Vanderbilt University Medical Center 24 participants Est. completion 2027-03 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Recruiting NCT NCT06396416
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Not yet reported Western University, Canada 60 participants Est. completion 2026-12 1 siteChronic kidney disease Other conditions: ObesityView official trial listing → -
Recruiting NCT NCT06410352
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
Not yet reported University Medical Center, Kazakhstan 220 participants Est. completion 2026-07-31 1 siteMetabolic syndromeView official trial listing → -
Recruiting NCT NCT06461377
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
Not yet reported The First Affiliated Hospital with Nanjing Medical University 50 participants Est. completion 2027-12-31 1 site Added to GLP-1Type 2 diabetes Other conditions: Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)View official trial listing → -
Recruiting NCT NCT06582875
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
Not yet reported University of Colorado, Denver 126 participants Est. completion 2029-06-30 1 siteOther conditions: Autosomal Dominant Polycystic Kidney, ObesityView official trial listing → -
Recruiting NCT NCT06630585
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
Not yet reported University of Bern 42 participants Est. completion 2026-06 3 sitesOther conditions: Type 1 Diabetes (T1D)View official trial listing → -
Recruiting NCT NCT06686134
Comprehensive Clinical Evaluation Study of GLP-1RA
LI YAN 492 participants Est. completion 2026-07-31 1 siteType 2 diabetesView official trial listing → -
Recruiting NCT NCT06792422
A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
Not yet reported Glostrup University Hospital, Copenhagen 126 participants Est. completion 2028-12 1 siteOther conditions: Primary Open Angle Glaucoma (POAG), Open-Angle Glaucoma, GlaucomaView official trial listing → -
Recruiting NCT NCT06825182
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
Not yet reported Nanjing First Hospital, Nanjing Medical University 1000 participants Est. completion 2025-12-31 1 siteType 2 diabetesView official trial listing → -
Recruiting NCT NCT06889454
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
Attikon Hospital 120 participants Est. completion 2026-02-01 1 siteMetabolic syndrome Other conditions: PCOS, Hyperinsulinism, HyperandrogenismView official trial listing → -
Recruiting NCT NCT06989177
Probiotic Intervention on Body Weight
Not yet reported Chinese Academy of Sciences 140 participants Est. completion 2026-12-31 1 siteOther conditions: Obesity, Homeostasis, Weight Loss, Probiotic InterventionView official trial listing → -
Recruiting NCT NCT06989203
Protein Supplementation Intervention on Body Weight
Not yet reported Chinese Academy of Sciences 140 participants Est. completion 2026-12-31 1 site Added to GLP-1Other conditions: Obesity, Weight Loss, Protein SupplementationView official trial listing → -
Recruiting NCT NCT07017270
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
Not yet reported Unity Health Toronto 100 participants Est. completion 2027-09 2 sitesOther conditions: Kidney Disease, Chronic, Diabetes, Dialysis, End Stage Kidney Disease (ESRD)View official trial listing → -
Recruiting NCT NCT07107334
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
Not yet reported University of Florida 20 participants Est. completion 2029-11 1 siteOther conditions: Endometrioid Endometrial AdenocarcinomaView official trial listing → -
Recruiting NCT NCT07178145
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
Not yet reported University of Virginia 192 participants Est. completion 2029-12 1 site Stand-aloneHeart failure Other conditions: Epicardial Adipose TissueView official trial listing → -
Recruiting NCT NCT07244003
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430 participants Est. completion 2028-06-30 1 site Added to GLP-1Type 2 diabetesView official trial listing → -
Recruiting NCT NCT07309094
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Cardenal Herrera University 250 participants Est. completion 2028-12-31 1 siteChronic kidney diseaseType 2 diabetes Other conditions: ObesityView official trial listing → -
Recruiting NCT NCT07317115
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
Not yet reported GT Metabolic Solutions, Inc. 20 participants Est. completion 2028-06 1 siteType 2 diabetes Other conditions: Obesity (Disorder), Obesity & OverweightView official trial listing → -
Recruiting NCT NCT07457437
Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment
Not yet reported University of Exeter 60 participants Est. completion 2027-12-01 1 site Stand-aloneOther conditions: Muscle Mass and Strength, Obesity & Overweight, Physical FunctionView official trial listing → -
Recruiting NCT NCT07558863
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2028-08-30 1 site Added to GLP-1Type 2 diabetes Other conditions: Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)View official trial listing → -
Recruiting NCT NCT07575399
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Not yet reported Amgen 300 participants Est. completion 2028-02-28 45 sitesOther conditions: Obesity or OverweightView official trial listing → -
Recruiting NCT NCT07575932
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Not yet reported Pfizer 872 participants Est. completion 2028-01-05 65 sitesOther conditions: Overweight, Obesity, Overweight and/or Obesity, Overweight or Obesity, Overnutrition, Nutrition Disorders, Nutritional and Metabolic Diseases, Body WeightView official trial listing → -
Recruiting NCT NCT07702461
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Ohio State University 300 participants Est. completion 2027-01 1 siteOther conditions: Obesity & Overweight, Diabetes (DM)View official trial listing → -
Recruiting NCT NCT07720414
Effects of GLP-1 RAs on Human Lactation Outcomes
University of Colorado, Denver 18 participants Est. completion 2028-06 1 siteOther conditions: Lactation, Weight LossView official trial listing → -
Recruiting NCT NCT07723833
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
Not yet reported AstraZeneca 152 participants Est. completion 2026-11-18 2 sitesOther conditions: Healthy ParticipantsView official trial listing → -
Recruiting NCT NCT07732738
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.
Not yet reported China-Japan Friendship Hospital 400 participants Est. completion 2027-12-30 7 sitesOther conditions: ObesityView official trial listing → -
Recruiting NCT NCT07743567
Gestational Response, Outcomes, and Weight After GLP-1 Use
University of Kansas Medical Center 400 participants Est. completion 2028-04 1 siteOther conditions: Pregnant Individuals, Obesity & Overweight, Gestational Weight GainView official trial listing → -
Completed NCT NCT01744236
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
Not yet reported Amsterdam UMC, location VUmc 70 participants Est. completion 2015-08 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02055014
Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
Not yet reported Sandwell & West Birmingham Hospitals NHS Trust 72 participants Est. completion 2017-03 4 sites Stand-aloneType 2 diabetes Other conditions: Obesity, DiabesityView official trial listing → -
Completed NCT NCT02496611
Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
Not yet reported University of Minnesota 100 participants Est. completion 2020-08-14 1 siteOther conditions: Severe ObesityView official trial listing → -
Status unknown NCT NCT02584582
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Not yet reported, Not yet reported Hvidovre University Hospital 10 participantsOther conditions: Type 1 DiabetesView official trial listing → -
Withdrawn NCT NCT02920190
Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
Not yet reported University of Miami Est. completion 2021-12-31Other conditions: Monoclonal Gammopathies, Overweight, ObesityView official trial listing → -
Active, not recruiting NCT NCT03899402
Triple Therapy in T1DM
Not yet reported, Not yet reported State University of New York at Buffalo 78 participants Est. completion 2026-06-30 1 site Added to GLP-1Other conditions: Type 1 Diabetes MellitusView official trial listing → -
Status unknown NCT NCT03959865
GLP-1 REceptor Agonists and Real World EvIdeNce
University of Padova 6000 participants Est. completion 2019-05-31 6 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT04029272
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2020-12-31 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Status unknown NCT NCT04137328
Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
Not yet reported Fudan University 60 participants Est. completion 2022-11-30Other conditions: Diabetic Neuropathic PainView official trial listing → -
Completed NCT NCT04184947
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
University of Padova 10000 participants Est. completion 2020-02-29 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT04196231
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
Not yet reported University of Campania Luigi Vanvitelli 258 participants Est. completion 2020-10-20 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT04504370
Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
Not yet reported PegBio Co., Ltd. 273 participants Est. completion 2022-11-28 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04504396
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
Not yet reported PegBio Co., Ltd. 620 participants Est. completion 2023-05-26 1 site Stand-aloneType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT04892199
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Not yet reported Anders Fink-Jensen, MD, DMSci 104 participants Est. completion 2026-08-01 3 sitesType 2 diabetes Other conditions: Metabolic Disturbance, Schizophrenia, Clozapine, GLP-1, OlanzapineView official trial listing → -
Completed NCT NCT05073692
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Kaiser Permanente 241981 participants Est. completion 2025-03-12 6 sitesType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT05177653
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
Not yet reported University Hospital, Gentofte, Copenhagen 13 participants Est. completion 2023-03-03 1 site Stand-aloneOther conditions: Pancreatectomy; HyperglycemiaView official trial listing → -
Completed NCT NCT05214573
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
Mayo Clinic 386301 participants Est. completion 2025-07-22 1 siteType 2 diabetes Other conditions: Cardiac DiseaseView official trial listing → -
Active, not recruiting NCT NCT05220917
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 siteType 2 diabetes Other conditions: Cardiovascular Events, Renal DiseaseView official trial listing → -
Terminated NCT NCT05297045
A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
Not yet reported Regor Pharmaceuticals Inc. 17 participants Est. completion 2023-05-30 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT05390307
Obesity Treatment to Improve Diabetes
Not yet reported Dasman Diabetes Institute 60 participants Est. completion 2024-01-01 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT05535322
Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity
Ana Palanca 26944 participants Est. completion 2022-09-01 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Status unknown NCT NCT05578352
The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy
Not yet reported Nanjing First Hospital, Nanjing Medical University 20 participants Est. completion 2023-01-31 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT05779644
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
Not yet reported RenJi Hospital 300 participants Est. completion 2025-02-23 1 siteType 2 diabetes Other conditions: Metformin, Obesity, Abdominal, Abdominal Fat, Non-Alcoholic Fatty Liver Disease, Metabolism Disorder, Glucose, Metabolism Disorder, LipidView official trial listing → -
Status unknown NCT NCT05948969
Transform CV Risk in Diabetes
Not yet reported American College of Cardiology 750 participants Est. completion 2024-12-31 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT06344247
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
Not yet reported RenJi Hospital 48 participants Est. completion 2025-12-01 1 site Added to GLP-1Chronic kidney disease Other conditions: ObesityView official trial listing → -
Status unknown NCT NCT06449235
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 siteOther conditions: Type2diabetesView official trial listing → -
Completed NCT NCT06500143
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
Ciusss de L'Est de l'Île de Montréal 94 participants Est. completion 2025-02-28 1 siteOther conditions: Gastric RetentionView official trial listing → -
Active, not recruiting NCT NCT06777238
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
Not yet reported Gan & Lee Pharmaceuticals. 274 participants Est. completion 2027-03-10 1 siteType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT06807970
Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist
Not yet reported The University of Hong Kong 54 participants Est. completion 2028-07-01 1 site Stand-aloneOsteoarthritisView official trial listing → -
Completed NCT NCT06938529
A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function
Not yet reported Vincentage Pharma Co., Ltd 24 participants Est. completion 2025-07-25 1 site Stand-aloneOther conditions: Obesity, OverweightView official trial listing → -
Active, not recruiting NCT NCT06939517
Acupressure Wristbands for GLP-1RA Related Nausea
Not yet reported Florencia Ziemke 35 participants Est. completion 2025-04-13 1 siteOther conditions: NauseaView official trial listing → -
Completed NCT NCT06967337
Microsteps Study-Short, Animated Storytelling Video
Not yet reported Stanford University 5431 participants Est. completion 2025-07-21 1 site Stand-aloneOther conditions: Behavior, HealthView official trial listing → -
Active, not recruiting NCT NCT07115069
Comparison of Body Composition Changes With Weight Loss Interventions
Vanderbilt University Medical Center 60 participants Est. completion 2027-12 1 siteOther conditions: ObesityView official trial listing → -
Not yet recruiting NCT NCT07140055
A Research Study to Evaluate BLX-7006 in Healthy Adults
Not yet reported Biolexis Therapeutics 76 participants Est. completion 2026-05 1 siteOther conditions: Normal Healthy Volunteer, Safety After Oral IntakeView official trial listing → -
Not yet recruiting NCT NCT07156331
Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
Kristin Clemens 20 participants Est. completion 2027-12-31Type 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT07188545
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Ohio State University 23280000 participants Est. completion 2029-06-30 1 siteMetabolic syndromeView official trial listing → -
Not yet recruiting NCT NCT07276763
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
Fudan University 16509 participants Est. completion 2025-12-15 1 siteOther conditions: Gastric RetentionView official trial listing → -
Active, not recruiting NCT NCT07311850
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Not yet reported Pfizer 3578 participants Est. completion 2028-04-25 169 sitesOther conditions: Obesity and OverweightView official trial listing → -
Active, not recruiting NCT NCT07325435
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
Not yet reported MaryAnn Banerji 60 participants Est. completion 2028-06-30 1 siteType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT07400653
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
Not yet reported Pfizer 1078 participants Est. completion 2028-05-16 188 sitesType 2 diabetes Other conditions: Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2View official trial listing → -
Active, not recruiting NCT NCT07422987
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
University of Kansas Medical Center 50 participants Est. completion 2027-06-30 1 siteOther conditions: Body Composition, Muscle Function, GLP-1, Estrogen LevelView official trial listing → -
Completed NCT NCT07451938
A Cohort Study on Obese Patients' Multidisciplinary Integrated Health Management
China-Japan Friendship Hospital 1500 participants Est. completion 2025-07-30 1 siteOther conditions: Obesity, Diabete Type 2, Bariatric SurgeryView official trial listing → -
Not yet recruiting NCT NCT07550634
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment
Not yet reported MindRank AI Ltd 32 participants Est. completion 2026-10-30 1 siteOther conditions: Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), Hepatic Insufficiency (MeSH ID: D048550)View official trial listing → -
Completed NCT NCT07611201
The Effects of GLP-1 Receptor Agonists on Chemosensory Function and Ingestive Behavior
Purdue University 90 participants Est. completion 2026-05-04 1 site Stand-aloneOther conditions: Obesity, Overweight, Taste Perception, Olfaction, Eating Behavior, AppetiteView official trial listing → -
Not yet recruiting NCT NCT07625774
Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease
Not yet reported Shandong Suncadia Medicine Co., Ltd. 3690 participants Est. completion 2031-07 2 sitesChronic kidney diseaseView official trial listing → -
Completed NCT NCT07627048
Influence of Gut Microbiota on the Development of Type 2 Diabetes Mellitus and Personalization of Diabetes-lowing Therapy
Pirogov Russian National Research Medical University 100 participants Est. completion 2022-04-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT07628556
Antidiabetic Medications and Risk of Cancer
University of Pecs 74799 participants Est. completion 2025-12-30 1 siteOther conditions: CancerView official trial listing → -
Not yet recruiting NCT NCT07657676
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
Not yet reported China National Center for Cardiovascular Diseases 116 participants Est. completion 2027-12-31 1 siteOther conditions: Obesity & Overweight, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT07677865
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
West China Hospital 213891 participants Est. completion 2026-06-24 1 siteType 2 diabetes Other conditions: Alzheimer Disease, Obesity & OverweightView official trial listing → -
Not yet recruiting NCT NCT07723820
Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)
Thammasat University Hospital 126 participants Est. completion 2027-09-01 1 siteType 2 diabetes Other conditions: Diabetic Retinopathy (DR)View official trial listing → -
Not yet recruiting NCT NCT07784127
Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation
Not yet reported The Cleveland Clinic 20 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Not yet recruiting NCT NCT07787533
Digital Resistance Training for Midlife Women Using GLP-1
Not yet reported Louisiana State University and A&M College 15 participants Est. completion 2027-06-30 1 site Stand-aloneOther conditions: Women's Health, Obesity & Overweight, Perimenopausal Women, Digital Intervention, Behavior Change, glp1 Agonist, Resistance ExerciseView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.